DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE
LIVE

Serial Number

90217844

Owner

Bayer Aktiengesellschaft

Attorney

Phillip Barengolts

First Use Date

Jul 30, 2019

Filing Date

Sep 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE Trademark

Serial Number: 90217844 • Registration: 6308950

DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE is a trademark filed by Bayer Aktiengesellschaft on September 28, 2020. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Bayer Aktiengesellschaft (27 trademarks)

Kaiser-Wilhelm-Allee, 1
Leverkusen 51373 , DE

Entity Type: 99

Trademark Details

Filing Date

September 28, 2020

Registration Date

March 30, 2021

First Use Anywhere

July 30, 2019

First Use in Commerce

July 30, 2019

Published for Opposition

January 12, 2021

Goods & Services

Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs

Business administration of patient reimbursement programs; Business administration of pharmaceutical reimbursement programs and services; Business management of reimbursement programs for others; Strategic business planning and consultation in the field of reimbursement support for pharmaceutical products; Business administration of support programs for patients to access co-pay assistance and other funding sources to pay for specialty medications

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 30, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 30, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 23, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2020 CNSA
ASSIGNED TO EXAMINER
Dec 2, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 10, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2020 NWOS
NEW APPLICATION ENTERED
Oct 1, 2020 NWAP